Among these mediators, it is worth noting the case of IFNα, since type-I interferons play a role in the pathogenesis of SLE and probably other autoimmune diseases [14], and recent evidence suggests their involvement in endothelial damage and EPC dysfunction. Here, IFNA1 is linked to systemic lupus erythematosus.